HUTCHMED (China) (HCM) Dividends payables (2019)
HUTCHMED (China) (HCM) reported Dividends payables of -$14.6 million for Q4 2019.
HUTCHMED (China) (HCM) Dividends payables (2019) Analysis & Trends
HUTCHMED (China) (HCM) has 1 years of Dividends payables data on file, last reported at -$14.6 million in Q4 2019.
- Dividends payables for Q4 2019 came in at -$14.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was -$14.6 million (changed N/A YoY), and the FY2019 annual result was -$14.6 million, changed N/A from the prior year.
- Dividends payables was little changed at -$14.6 million in Q4 2019 per HCM's latest filing.
- Over five years, Dividends payables peaked at -$14.6 million in Q4 2019 and troughed at -$14.6 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 224.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -14.62 Mn |